{"schema_version":"1","generated_at":"2026-11-08T21:08:58.197Z","data_as_of":null,"url":"https://www.findmykol.com/kol/david-antezana","json_url":"https://www.findmykol.com/kol/david-antezana/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"david-antezana","name":"David Antezana","credential":"MD","specialty":"Neurological Surgery","specialty_raw":"Neurological Surgery","therapeutic_area":"Neurology","therapeutic_areas":["Neurology"],"city":"Portland","state":"OR","region":{"label":"West","url":"https://www.findmykol.com/region/west"}},"identifiers":{"npi":"1225024052","openalex":"A5075688991"},"summary":"David Antezana is a Neurology physician. OpenAlex indexes 12 publications with 1,583 citations (h-index 8).","overview":null,"focus":{"indications":[],"research_topics":["Neurology"]},"scholarship":{"works_count":12,"cited_by_count":1583,"h_index":8,"latest_activity_year":2025,"source":"works"},"payments":{"company_count":10,"program_years":{"first":2021,"last":null},"rows_total":22,"shown":3,"withheld":19,"rows":[{"payer":"Globus Medical, Inc.","program_year":2025,"amount_usd":8997.35,"payment_count":15,"source_url":"https://openpaymentsdata.cms.gov/search?query=1225024052"},{"payer":"Abbott Laboratories","program_year":2025,"amount_usd":353.31,"payment_count":3,"source_url":"https://openpaymentsdata.cms.gov/search?query=1225024052"},{"payer":"Elekta, Inc.","program_year":2025,"amount_usd":79.67,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1225024052"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1225024052","source":"payments"},"publications":{"total":12,"shown":5,"withheld":7,"matched_by":"OpenAlex author record","recent":[{"title":"Longitudinal transcriptomics define the stages of myeloid activation in the living human brain after intracerebral hemorrhage","year":2021,"journal":"Science Immunology","source_url":"https://doi.org/10.1126/sciimmunol.abd6279","status":"verified"},{"title":"Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): a randomised, controlled, open-label, blinded endpoint phase 3 trial","year":2019,"journal":"The Lancet","source_url":"https://doi.org/10.1016/s0140-6736(19)30195-3","status":"verified"},{"title":"Surgical Performance Determines Functional Outcome Benefit in the Minimally Invasive Surgery Plus Recombinant Tissue Plasminogen Activator for Intracerebral Hemorrhage Evacuation (MISTIE) Procedure","year":2019,"journal":"Neurosurgery","source_url":"https://doi.org/10.1093/neuros/nyz077","status":"verified"},{"title":"CSF inflammatory response after intraventricular hemorrhage","year":2017,"journal":"Neurology","source_url":"https://doi.org/10.1212/wnl.0000000000004493","status":"verified"},{"title":"Accuracy of the ABC/2 Score for Intracerebral Hemorrhage","year":2015,"journal":"Stroke","source_url":"https://doi.org/10.1161/strokeaha.114.007343","status":"verified"}],"source":"works"},"similar":[{"name":"Bruce Miller","slug":"bruce-miller","institution":"University of California, San Francisco (UCSF)","specialty":"Neurology","url":"https://www.findmykol.com/kol/bruce-miller","json_url":"https://www.findmykol.com/kol/bruce-miller/profile.json"},{"name":"Brett Kissela","slug":"brett-kissela","institution":"Medical College of Wisconsin","specialty":"Neurology","url":"https://www.findmykol.com/kol/brett-kissela","json_url":"https://www.findmykol.com/kol/brett-kissela/profile.json"},{"name":"Richard Lipton","slug":"richard-lipton","institution":"Albert Einstein College of Medicine","specialty":"Neurology","url":"https://www.findmykol.com/kol/richard-lipton","json_url":"https://www.findmykol.com/kol/richard-lipton/profile.json"},{"name":"Bradley Boeve","slug":"bradley-boeve","institution":"Mayo Clinic","specialty":"Neurology","url":"https://www.findmykol.com/kol/bradley-boeve","json_url":"https://www.findmykol.com/kol/bradley-boeve/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":19,"publications":7}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"}},"methodology_url":"https://www.findmykol.com/about#methodology"}